UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Series A	Series A-1	Series B Preferred Stock	Class A Common Stock Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2020						3,379,400	1,837,600
Beginning balance at Dec. 31, 2020						$ 7,789	$ 10,270
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of Preferred Stock (in shares)						(3,379,400)	(1,837,600)
Conversion of preferred stock						$ (7,789)	$ (10,270)
Ending balance (in shares) at Mar. 31, 2021						0	0
Ending balance at Mar. 31, 2021						$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2020		95,050,041						4,681,400	0	0
Beginning balance at Dec. 31, 2020	$ (6,840)	$ 0	$ 4,975	$ 0	$ (35,815)			$ 24,000	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)		29,695,200						(4,681,400)
Conversion of preferred stock	18,058		42,058					$ (24,000)
Issuance of Class A Common Stock in connection with the Initial Public Offering, net of issuance costs (in shares)									10,000,000
Issuance of Class A Common Stock in connection with the initial public offering, net of $13,378 in issuance costs	126,622		126,622
Reclassification of Common Stock to Class B Common Stock in connection with the Initial Public Offering (in shares)		(124,745,241)								124,745,241
Reclassification of Common Stock to Class B Common Stock in connection with the initial public offering	0		(1)							$ 1
Exercise of stock options (in shares)										3,861
Exercise of stock options	7		7
Stock-based compensation expense	593		593
Net income (loss)	1,471				1,471
Ending balance (in shares) at Mar. 31, 2021		0						0	10,000,000	124,749,102
Ending balance at Mar. 31, 2021	139,911	$ 0	174,254	0	(34,344)			$ 0	$ 0	$ 1
Beginning balance (in shares) at Dec. 31, 2020						3,379,400	1,837,600
Beginning balance at Dec. 31, 2020						$ 7,789	$ 10,270
Ending balance (in shares) at Jun. 30, 2021						0	0
Ending balance at Jun. 30, 2021						$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2020		95,050,041						4,681,400	0	0
Beginning balance at Dec. 31, 2020	(6,840)	$ 0	4,975	0	(35,815)			$ 24,000	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Foreign currency translation adjustments	0
Net income (loss)	1,192
Ending balance (in shares) at Jun. 30, 2021		0						0	10,800,368	124,696,442
Ending balance at Jun. 30, 2021	149,465	$ 0	184,087	0	(34,623)			$ 0	$ 0	$ 1
Beginning balance (in shares) at Mar. 31, 2021						0	0
Beginning balance at Mar. 31, 2021						$ 0	$ 0
Ending balance (in shares) at Jun. 30, 2021						0	0
Ending balance at Jun. 30, 2021						$ 0	$ 0
Beginning balance (in shares) at Mar. 31, 2021		0						0	10,000,000	124,749,102
Beginning balance at Mar. 31, 2021	139,911	$ 0	174,254	0	(34,344)			$ 0	$ 0	$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)									81,102	(81,102)
Issuance of Class A Common Stock in connection with the Initial Public Offering, net of issuance costs (in shares)									719,266
Issuance of Class A Common Stock in connection with the initial public offering, net of $13,378 in issuance costs	9,245		9,245
Exercise of stock options (in shares)										28,442
Exercise of stock options	19		19
Stock-based compensation expense	569		569
Foreign currency translation adjustments	0
Net income (loss)	(279)				(279)
Ending balance (in shares) at Jun. 30, 2021		0						0	10,800,368	124,696,442
Ending balance at Jun. 30, 2021	149,465	$ 0	184,087	0	(34,623)			$ 0	$ 0	$ 1
Beginning balance (in shares) at Dec. 31, 2021						0	0
Beginning balance at Dec. 31, 2021						$ 0	$ 0
Ending balance (in shares) at Mar. 31, 2022						0	0
Ending balance at Mar. 31, 2022						$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2021		0						0	31,841,061	108,870,126
Beginning balance at Dec. 31, 2021	225,542	$ 0	264,871	(230)	(39,100)			$ 0	$ 0	$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)									10,842,862	(10,842,862)
Exercise of stock options (in shares)									197,828
Exercise of stock options	924		924
Issuance of shares in connection with ESPP (in shares)									39,516
Vesting of Class A Common Stock in connection with Restricted Stock Units (in shares)									14,625
Stock-based compensation expense	932		932
Foreign currency translation adjustments	(264)			(264)
Net income (loss)	(2,571)				(2,571)
Ending balance (in shares) at Mar. 31, 2022		0						0	42,935,892	98,027,264
Ending balance at Mar. 31, 2022	224,563	$ 0	266,727	(494)	(41,671)			$ 0	$ 0	$ 1
Beginning balance (in shares) at Dec. 31, 2021						0	0
Beginning balance at Dec. 31, 2021						$ 0	$ 0
Ending balance (in shares) at Jun. 30, 2022						0	0
Ending balance at Jun. 30, 2022						$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2021		0						0	31,841,061	108,870,126
Beginning balance at Dec. 31, 2021	$ 225,542	$ 0	264,871	(230)	(39,100)			$ 0	$ 0	$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	341,495
Foreign currency translation adjustments	$ (1,121)
Net income (loss)	(10,855)				(8,284)
Ending balance (in shares) at Jun. 30, 2022		0						0	43,261,183	97,870,664
Ending balance at Jun. 30, 2022	217,896	$ 0	269,201	(1,351)	(49,955)			$ 0	$ 0	$ 1
Beginning balance (in shares) at Mar. 31, 2022						0	0
Beginning balance at Mar. 31, 2022						$ 0	$ 0
Ending balance (in shares) at Jun. 30, 2022						0	0
Ending balance at Jun. 30, 2022						$ 0	$ 0
Beginning balance (in shares) at Mar. 31, 2022		0						0	42,935,892	98,027,264
Beginning balance at Mar. 31, 2022	224,563	$ 0	266,727	(494)	(41,671)			$ 0	$ 0	$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)									156,600	(156,600)
Exercise of stock options (in shares)									143,667
Exercise of stock options	$ 270		270
Vesting of Class A Common Stock in connection with Restricted Stock Units (in shares)	51,762								25,024
Stock-based compensation expense	$ 2,204		2,204
Foreign currency translation adjustments	(857)			(857)
Net income (loss)	(8,284)
Ending balance (in shares) at Jun. 30, 2022		0						0	43,261,183	97,870,664
Ending balance at Jun. 30, 2022	$ 217,896	$ 0	$ 269,201	$ (1,351)	$ (49,955)			$ 0	$ 0	$ 1